We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is COMPASS Pathways PLC Sponsored ADR (CMPS - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
COMPASS Pathways PLC Sponsored ADR is a member of the Medical sector. This group includes 890 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. COMPASS Pathways PLC Sponsored ADR is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for CMPS' full-year earnings has moved 23.4% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
According to our latest data, CMPS has moved about 32.6% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -7.1% on a year-to-date basis. This means that COMPASS Pathways PLC Sponsored ADR is outperforming the sector as a whole this year.
Another stock in the Medical sector, DBV Technologies S.A. (DBVT - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 0.9%.
For DBV Technologies S.A., the consensus EPS estimate for the current year has increased 53.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, COMPASS Pathways PLC Sponsored ADR belongs to the Medical Services industry, a group that includes 62 individual stocks and currently sits at #86 in the Zacks Industry Rank. On average, this group has lost an average of 11.8% so far this year, meaning that CMPS is performing better in terms of year-to-date returns.
In contrast, DBV Technologies S.A. falls under the Medical - Biomedical and Genetics industry. Currently, this industry has 435 stocks and is ranked #96. Since the beginning of the year, the industry has moved +0.4%.
Investors interested in the Medical sector may want to keep a close eye on COMPASS Pathways PLC Sponsored ADR and DBV Technologies S.A. as they attempt to continue their solid performance.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is COMPASS Pathways PLC Sponsored ADR (CMPS - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
COMPASS Pathways PLC Sponsored ADR is a member of the Medical sector. This group includes 890 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. COMPASS Pathways PLC Sponsored ADR is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for CMPS' full-year earnings has moved 23.4% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
According to our latest data, CMPS has moved about 32.6% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -7.1% on a year-to-date basis. This means that COMPASS Pathways PLC Sponsored ADR is outperforming the sector as a whole this year.
Another stock in the Medical sector, DBV Technologies S.A. (DBVT - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 0.9%.
For DBV Technologies S.A., the consensus EPS estimate for the current year has increased 53.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, COMPASS Pathways PLC Sponsored ADR belongs to the Medical Services industry, a group that includes 62 individual stocks and currently sits at #86 in the Zacks Industry Rank. On average, this group has lost an average of 11.8% so far this year, meaning that CMPS is performing better in terms of year-to-date returns.
In contrast, DBV Technologies S.A. falls under the Medical - Biomedical and Genetics industry. Currently, this industry has 435 stocks and is ranked #96. Since the beginning of the year, the industry has moved +0.4%.
Investors interested in the Medical sector may want to keep a close eye on COMPASS Pathways PLC Sponsored ADR and DBV Technologies S.A. as they attempt to continue their solid performance.